Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
gamma-pn3
- Development stage
- Phase 2
- Lead developer
- GPN Vaccines
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Intranasal
01
Overview
Gamma-PN3 is an inactivated whole-cell pneumococcal vaccine under development by GPN Vaccines for the prevention of pneumococcal disease, including pneumonia caused by Streptococcus pneumoniae. It is a next-generation version of Gamma-PN, designed to induce broad immunity against all pneumococcal strains. The vaccine consists of a gamma-irradiated, unencapsulated Streptococcus pneumoniae strain and is administered intramuscularly or intranasally. Gamma-PN3 acts as an immunostimulant, aiming to elicit robust antibody responses across diverse serotypes. Clinical trials are ongoing in elderly adults and other populations at risk for severe pneumococcal infections[1][2][3][4][5].
- Other names
- Gamma-PN3Gamma-PN-3Gamma-PN 3
Beyond the preview
Go deeper on gamma-pn3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on gamma-pn3.